Active Biotech Receives 550000 Euro from Vinnova

Active Biotech AB has received 550000 Euro from Vinnova's, Swedish Governmental Agency for Innovation Systems, program Research and Grow. The funds will be used within a pre-clinical project for the development of a new generation of pharmaceuticals for the treatment of autoimmune/inflammatory diseases. The project is partly performed in collaboration with scientists at Lund University.

For further information please contact:

Cecilia Hofvander,
Manager Corporate Communication
Tel: +46 46 19 11 22
Email: cecilia.hofvander@activebiotech.com

Or visit: www.activebiotech.com

Home > News & Events > News > Active Biotech Receives 550000 Euro from Vinnova
Last updated: 2006-11-24

The official Medicon Valley site is brought to you by the organisations Region Skåne and Copenhagen Capacity - in association with Medicon Valley Alliance

Contact:
Copenhagen Capacity,	tel: +45 33 22 02 22
Region Skåne,	tel: +46 (0)40 623 97 48

ACTIVE BIOTECH AB

ACTIVE BIOTECH AB

Active Biotech is a publicly traded Swedish biotechnology company. The company has five projects in clinical development for the treatment of serious autoimmune/inflammatory diseases and cancer. Laquinimod - a novel oral treatment of multiple sclerosis – is developed through a cooperation with Teva ...